6.
Mishima K, Kitoh H, Katagiri T, Kaneko H, Ishiguro N
. Early clinical and radiographic characteristics in fibrodysplasia ossificans progressiva: a report of two cases. J Bone Joint Surg Am. 2011; 93(10):e52.
DOI: 10.2106/JBJS.J.01443.
View
7.
Hino K, Horigome K, Nishio M, Komura S, Nagata S, Zhao C
. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. J Clin Invest. 2017; 127(9):3339-3352.
PMC: 5669572.
DOI: 10.1172/JCI93521.
View
8.
Kaplan F, Al Mukaddam M, Stanley A, Towler O, Shore E
. Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis. Bone. 2020; 140:115539.
PMC: 7502483.
DOI: 10.1016/j.bone.2020.115539.
View
9.
Bertamino M, Severino M, Schiaffino M, Garre M, Bocciardi R, Ravazzolo R
. New insights into central nervous system involvement in FOP: Case report and review of the literature. Am J Med Genet A. 2015; 167A(11):2817-21.
DOI: 10.1002/ajmg.a.37271.
View
10.
Petersen M, Ryu J, Chang K, Etxeberria A, Bardehle S, Mendiola A
. Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage. Neuron. 2017; 96(5):1003-1012.e7.
PMC: 5851281.
DOI: 10.1016/j.neuron.2017.10.008.
View
11.
Wang Y, Cheng X, He Q, Zheng Y, Kim D, Whittemore S
. Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci. 2011; 31(16):6053-8.
PMC: 3081104.
DOI: 10.1523/JNEUROSCI.5524-09.2011.
View
12.
Kan L, Kitterman J, Procissi D, Chakkalakal S, Peng C, McGuire T
. CNS demyelination in fibrodysplasia ossificans progressiva. J Neurol. 2012; 259(12):2644-55.
PMC: 3894630.
DOI: 10.1007/s00415-012-6563-x.
View
13.
Hino K, Ikeya M, Horigome K, Matsumoto Y, Ebise H, Nishio M
. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Proc Natl Acad Sci U S A. 2015; 112(50):15438-43.
PMC: 4687587.
DOI: 10.1073/pnas.1510540112.
View
14.
Khan F, Yu X, Hsiao E
. Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva. Biomedicines. 2021; 9(2).
PMC: 7915901.
DOI: 10.3390/biomedicines9020155.
View
15.
Pignolo R, Bedford-Gay C, Liljesthrom M, Durbin-Johnson B, Shore E, Rocke D
. The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment. J Bone Miner Res. 2016; 31(3):650-6.
PMC: 4829946.
DOI: 10.1002/jbmr.2728.
View
16.
Shore E, Xu M, Feldman G, Fenstermacher D, Cho T, Choi I
. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006; 38(5):525-7.
DOI: 10.1038/ng1783.
View
17.
Cepela D, Tartaglione J, Dooley T, Patel P
. Classifications In Brief: Salter-Harris Classification of Pediatric Physeal Fractures. Clin Orthop Relat Res. 2016; 474(11):2531-2537.
PMC: 5052189.
DOI: 10.1007/s11999-016-4891-3.
View
18.
Lindborg C, Al Mukaddam M, Baujat G, Cho T, De Cunto C, Delai P
. Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility. Clin Orthop Relat Res. 2023; 481(12):2447-2458.
PMC: 10642855.
DOI: 10.1097/CORR.0000000000002672.
View